Related Experiment Video
Updated: Jun 25, 2026

08:52
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
Perspectives on eGFR reporting from the interface between primary and secondary care
Chee Kay Cheung1, Sunil Bhandari
1Department of Renal Medicine, Hull Royal Infirmary, Hull and East Yorkshire Hospitals NHS Trust, Hull, United Kingdom. chee.cheung@hey.nhs.uk
Clinical Journal of the American Society of Nephrology : CJASN
|February 10, 2009
Summary
Estimated glomerular filtration rate (eGFR) reporting offers a valuable tool for stratifying cardiovascular disease risk in the general population. This approach can improve patient outcomes by identifying at-risk individuals for targeted interventions.
Area of Science:
- Nephrology
- Public Health
- Cardiovascular Medicine
Background:
- Automated reporting of estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) equation is debated for its community-wide value.
- Concerns exist regarding the MDRD equation's inaccuracies in specific populations, potentially leading to a "worried well" phenomenon and resource implications.
- Chronic kidney disease significantly increases cardiovascular disease risk, yet risk factors are often inadequately managed.
Purpose of the Study:
- To evaluate the utility of eGFR reporting in risk stratification for cardiovascular disease.
- To explore the potential of eGFR reporting to improve patient outcomes in a broad population.
- To address concerns surrounding the use of eGFR as a "covert" screening tool.
Main Methods:
- Analysis of eGFR reporting data.
- Assessment of the MDRD equation's performance in diverse populations.
- Review of existing literature on chronic kidney disease and cardiovascular risk.
Main Results:
- The study posits that eGFR reporting provides an opportunity for risk stratification.
- Potential for improved patient outcomes through targeted management of cardiovascular risk factors in those identified by eGFR.
Conclusions:
- eGFR reporting, despite debates on the MDRD equation's accuracy, can be a powerful tool for identifying individuals at increased risk of cardiovascular disease.
- Leveraging eGFR data allows for proactive health management, potentially mitigating adverse outcomes and optimizing resource allocation.
Related Concept Videos
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Secondary Healthcare System
Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...